Table 1.
Baseline clinical characteristics of the non-GEJ-treated group and the GEJ-treated group.
| Variables | Non-GEJ-treated group (n = 21) | GEJ-treated group (n = 21) | P value | ||||
|---|---|---|---|---|---|---|---|
| Median | P 25 | P 75 | Median | P 25 | P 75 | ||
| Age, years | 83.00 | 81.00 | 87.00 | 82.00 | 80.00 | 86.00 | 0.528 |
| BMI, kg/m2 | 24.39 | 23.11 | 25.16 | 23.44 | 21.23 | 25.79 | 0.462 |
| ADL | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 0.075 |
| Lequesne index | 4.00 | 0.00 | 6.00 | 6.00 | 3.00 | 9.00 | 0.108 |
| Test for balance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.317 |
| PeakTQ-ext-nondominant (Nm) | 31.60 | 21.50 | 52.90 | 38.80 | 18.20 | 45.90 | 0.725 |
| PeakTQ-ext-dominant (Nm) | 25.70 | 12.00 | 52.50 | 29.10 | 19.50 | 49.60 | 0.624 |
| PeakTQ-flex-nondominant (Nm) | 17.40 | 11.60 | 26.70 | 19.50 | 14.40 | 32.60 | 0.801 |
| PeakTQ-flex-dominant (Nm) | 17.30 | 10.80 | 28.90 | 18.80 | 15.70 | 33.20 | 0.345 |
| TQ/BW-ext-nondominant (ft·lb/lb) | 43.10 | 29.60 | 93.10 | 66.60 | 35.30 | 83.10 | 0.538 |
| TQ/BW-ext-dominant (ft·lb/lb) | 34.80 | 18.20 | 77.10 | 57.80 | 27.40 | 82.40 | 0.365 |
| TQ/BW-flex-nondominant (ft·lb/lb) | 26.30 | 16.40 | 40.20 | 33.00 | 24.40 | 51.20 | 0.473 |
| TQ/BW-flex-dominant (ft·lb/lb) | 25.50 | 17.90 | 46.10 | 37.30 | 24.20 | 53.80 | 0.204 |
Mann-Whitney U test; ∗P < 0.05.